To evaluate the efficacy of yapana basti(medicated enema) and nasya (nasal drops)along with shirobasti followed by kauncha paka in the management of kampavata with special reference to parkinson’s disease (pd)

A comparative clinical study to evaluate the efficacy of yapana basti and nasya along with shirobasti followed by kauncha paka in the management of kampavata with special reference to Parkinson’s disease (PD).

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043053

Enrollment

Registered

2022-06-07

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G20- Parkinsons disease

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: . Patients between 40-70 years of age. 2. Patients with clinical signs and symptoms of Kampavata/ PD. 3. Patients of either sex irrespective of their occupation, religion and socio-economic status. 4. Patients of Kampavata/PD who are fit for Shirobasti , Basti and Nasya. 5. Patients willing to participate for interventional study.

Exclusion criteria

Exclusion criteria: . Patients with severe systemic disorders as Uncontrolled Hypertension, Cardiac Problem, Uncontrolled Diabetes Mellitus, Tuberculosis, Leprosy, Paralysis, malignant disease etc. 2. Patients unfit for Shirobasti , Basti and Nasya.

Design outcomes

Primary

Measure	Time frame
Assessment of changes will be assessed on the basis of UPDRS (Unified Parkinson’s disease Rating Scale) (modified) before and after the treatment.Timepoint: Assessment will be done at Day 0, Day 16, Day 31 and after follow-up of 15 days	—

Secondary

Measure	Time frame
Assessment of changes in following specific signs and symptoms of Kampavata 1 kampa 2 chestasang 3 stambha 4 gati vikriti 5 avanamna 6 vak vikriti (PD). Timepoint: at the base line day and After completion of trial.	—

Countries

India

Contacts

Public ContactDrRaj kumar jha

National Institute of Ayurveda

gmangal108@gmail.com8619849011

Outcome results